Future directions in tumor marker technology for prostate cancer.
This article assesses the likely role of PSA in the future management of patients with carcinoma of the prostate, taking into consideration new methods for measurement and assessment. In addition, novel tumor markers are discussed that may complement, or even perhaps replace, PSA.